Ceradyne Establishes New Ceramic Crucible Manufacturing Facility in China

Ceradyne, Inc. (NASDAQ: CRDN) announced the grand opening of its new 218,000-square-foot factory in Tianjin, China, Ceradyne Tianjin Advanced Materials.

This newly constructed facility will produce high-purity ceramic crucibles for the forming of large polysilicon ingots for use in the manufacturing of photovoltaic silicon solar cells.

The opening ceremonies were attended by customers from Europe, the U.S., Taiwan, Korea, Singapore, Malaysia and China. Suppliers and contractors from Italy, Mexico, the U.S. and China also attended along with Chinese employees and key Ceradyne executives, including Ceradyne ACO President David P. Reed and Ceradyne CFO Jerrold J. Pellizzon.

The new facility is located on Ceradyne's 13.7-acre plot in the Tianjin Airport Economic Area. The operation will be run by Ceradyne Chinese executives and engineers who have been trained by U.S.-based Ceradyne Thermo Materials' management.

Bruce Lockhart, Ceradyne Vice President responsible for the Company's solar energy efforts, commented: "This is a very exciting event for Ceradyne and particularly for Ceradyne Thermo Materials. It was only three and a half years ago that we opened the first crucible factory in Tianjin for the development and manufacture of high-technology ceramic crucibles to meet our Chinese customers' requirements."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.